These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18161636)

  • 1. Influence of loading volume of mefenamic acid on granules and tablet characteristics using a compaction simulator.
    Kimura G; Betz G; Leuenberger H
    Pharm Dev Technol; 2007; 12(6):627-35. PubMed ID: 18161636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of loading volume of mefenamic acid on granules and tablet characteristics using a compaction simulator.
    Kimura G; Betz G; Leuenberger H
    Pharm Dev Technol; 2008; 13(1):57-64. PubMed ID: 18300100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on mefenamic acid sustained release tablets with water-insoluble gel.
    Güngör S; Yildiz A; Ozsoy Y; Cevher E; Araman A
    Farmaco; 2003 May; 58(5):397-401. PubMed ID: 12729834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing capping and cracking of mefenamic acid tablets.
    Adam A; Schrimpl L; Schmidt PC
    Drug Dev Ind Pharm; 2000 May; 26(5):489-97. PubMed ID: 10789060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-inflammatory drug (mefenamic acid) incorporated in biodegradable alginate beads: development and optimization of the process using factorial design.
    Sevgi F; Kaynarsoy B; Ertan G
    Pharm Dev Technol; 2008; 13(1):5-13. PubMed ID: 18300095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of mefenamic acid sustained release beads based on kappa-carrageenan.
    Ozsoy Y; Bergişadi N
    Boll Chim Farm; 2000; 139(3):120-3. PubMed ID: 10961021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
    Kang N; Lee J; Choi JN; Mao C; Lee EH
    Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying the mechanism of aggregation of particles in high-shear granulation based on their surface properties by using micro-spectroscopy.
    Kano T; Yoshihashi Y; Yonemochi E; Terada K
    Int J Pharm; 2014 Jan; 461(1-2):495-504. PubMed ID: 24368102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percolation theory and the role of maize starch as a disintegrant for a low water-soluble drug.
    Kimura G; Puchkov M; Betz G; Leuenberger H
    Pharm Dev Technol; 2007; 12(1):11-9. PubMed ID: 17484140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of time-controlled triple-concentric mefenamic acid tablets for rheumatoid arthritis.
    Patel P; Madan P; Lin S
    Pharm Dev Technol; 2014 May; 19(3):355-62. PubMed ID: 23611159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An attempt to calculate in silico disintegration time of tablets containing mefenamic acid, a low water-soluble drug.
    Kimura G; Puchkov M; Leuenberger H
    J Pharm Sci; 2013 Jul; 102(7):2166-78. PubMed ID: 23613462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
    Andrews GP; Zhai H; Tipping S; Jones DS
    J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium mefenamate as a solution for the formulation and dissolution problems of mefenamic acid.
    Bani-Jaber A; Hamdan I; Al-Khalidi B
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1136-40. PubMed ID: 17666833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction.
    Wu SJ; Sun C
    J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.